Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1990-11-30
1992-05-19
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
530385, 514 6, 514832, 514833, 514 23, 514 60, 514769, 514777, A61K 3166, A61K 3170
Patent
active
051149320
ABSTRACT:
New blood substitutes are described having osmolarities greater than normal blood. The new blood substitues typically comprise a physiologically acceptable fluid electrolyte solution, a physiologically acceptable agent capable of increasing the osmolarity of the blood substitute to a value greater than normal blood, an oxygen carrying substance, and a sufficient amount of water to achieve the desired osmolarity. The blood substitutes of the present invention have osmolarities in the range of 500-800 milliosmoles per liter.
REFERENCES:
patent: 3679795 (1972-07-01), DeSomer et al.
patent: 3911915 (1975-10-01), Seifter et al.
patent: 3928574 (1975-12-01), Phillips
patent: 3937821 (1976-02-01), Irikura et al.
patent: 4740594 (1988-04-01), Mauzac et al.
patent: 4757052 (1988-07-01), Markov
patent: 4866096 (1989-09-01), Schweighardt
patent: 4873230 (1989-10-01), Belzer et al.
patent: 4908350 (1990-03-01), Kramer et al.
patent: 4927806 (1990-05-01), Kramer et al.
Angres Isaac A.
Griffin Ronald W.
O'Boyle James G.
LandOfFree
Hyperosmolar oxyreplete hemosubstitute does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hyperosmolar oxyreplete hemosubstitute, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hyperosmolar oxyreplete hemosubstitute will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2417571